Immune-mediated Drug-induced Liver Injury Caused by Laninamivir Octanoate Hydrate

2Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

We herein report the first case of immune-mediated drug-induced liver injury that may have been caused by laninamivir. A 15-year-old girl was diagnosed with influenza and prescribed 40 mg laninamivir. Six weeks later, she was admitted to our hospital because of jaundice and fatigue. Laboratory examinations revealed elevated levels of hepatobiliary enzymes, and acute liver injury was suspected. Laboratory examinations and histological findings were characteristic of autoimmune hepatitis. Steroid treatment was ineffective, and azathioprine was added to the treatment. Twenty-two months after the onset, a second biopsy revealed the absence of inflammatory infiltrations, and the drugs were withdrawn. Liver function tests remained normal nine months after withdrawal.

Cite

CITATION STYLE

APA

Kawaguchi, T., Arinaga-Hino, T., Shimizu, M., Tanikawa, K., Tokushige, T., Hirai, S., … Torimura, T. (2019). Immune-mediated Drug-induced Liver Injury Caused by Laninamivir Octanoate Hydrate. Internal Medicine, 58(17), 2501–2505. https://doi.org/10.2169/internalmedicine.2740-19

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free